Contineum Therapeutics (CTNM) Total Liabilities (2023 - 2026)

Contineum Therapeutics' Total Liabilities history runs 4 years deep, the most recent figure standing at $11.3 million for Q1 2026.

• In Q1 2026, Total Liabilities fell 16.21% year-over-year to $11.3 million; the TTM figure through Mar 2026 stood at $11.3 million (down 16.21% YoY), while the FY2025 annual figure was $15.7 million, up 5.9% from the prior year.
• Total Liabilities was $11.3 million for Q1 2026 at Contineum Therapeutics, down from $15.7 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $97.5 million in Q1 2023 to a low of $3.9 million in Q2 2024.
• Historically, Total Liabilities has averaged $24.1 million across 4 years, with a median of $11.5 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Total Liabilities plunged 93.26% in 2024, then jumped 198.49% in 2025.
• A 4-year view of Total Liabilities shows it stood at $5.7 million in 2023, then surged by 159.22% to $14.8 million in 2024, then grew by 5.9% to $15.7 million in 2025, then slipped by 27.76% to $11.3 million in 2026.
• The last three Total Liabilities figures came in at $11.3 million (Q1 2026), $15.7 million (Q4 2025), and $10.4 million (Q3 2025), per Business Quant data.